ZOLOFT
Drug
PFIZER INC.
Total Payments
$839,768
Transactions
348
Doctors
3
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $36,378 | 12 | 2 |
| 2018 | $270,491 | 126 | 0 |
| 2017 | $532,898 | 210 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $784,890 | 334 | 93.5% |
| Consulting Fee | $52,536 | 10 | 6.3% |
| Travel and Lodging | $2,343 | 4 | 0.3% |
Payments by Type
Research
$784,890
334 transactions
General
$54,878
14 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SPRITES SERTRALINE PEDIATRIC REGISTRY FOR THE EVALUATION OF SAFETY A NONINTERVENTIONAL LONGITUDINAL COHORT STUDY TO EVALUATE THE EFFECTS OF LONGTERM SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS | PFIZER INC. | $753,170 | 0 |
| SPRITES SERTRALINE PEDIATRIC REGISTRY FOR THE EVALUATION OF SAFETY A NONINTERVENTIONAL LONGITUDINAL COHORT STUDY TO EVALUATE THE EFFECTS OF LONGTERM SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS | Pfizer Inc. | $31,719 | 0 |
Ad
Manufacturing Companies
- PFIZER INC. $771,670
- Mylan Inc. $36,378
- Pfizer Inc. $31,719
Product Information
- Type Drug
- Total Payments $839,768
- Total Doctors 3
- Transactions 348
About ZOLOFT
ZOLOFT is a drug associated with $839,768 in payments to 3 healthcare providers, recorded across 348 transactions in the CMS Open Payments database. The primary manufacturer is PFIZER INC..
Payment data is available from 2017 to 2024. In 2024, $36,378 was paid across 12 transactions to 2 doctors.
The most common payment nature for ZOLOFT is "Unspecified" ($784,890, 93.5% of total).
ZOLOFT is associated with 2 research studies, including "SPRITES SERTRALINE PEDIATRIC REGISTRY FOR THE EVALUATION OF SAFETY A NONINTERVENTIONAL LONGITUDINAL COHORT STUDY TO EVALUATE THE EFFECTS OF LONGTERM SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS" ($753,170).